Apyx Medical Corporation Announces Appointment of Four Members to its Medical Advisory Board
July 15 2019 - 7:30AM
Business Wire
Apyx Medical Corporation, formerly Bovie Medical
Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical
devices and supplies and the developer of Helium Plasma Technology,
which is marketed and sold as Renuvion® in the cosmetic surgery
market and J-Plasma® in the hospital surgical market, today
announced the appointment of four members to its Medical Advisory
Board.
“Apyx Medical Corporation is pleased to appoint Dr. Brian M.
Kinney, Dr. Paul G. Ruff, Dr. Richard D. Gentile and Dr. Edward M.
Zimmerman to our Medical Advisory Board,” said Charlie Goodwin,
President and Chief Executive Officer. “With the addition of these
four experts in the fields of plastic and cosmetic surgery, which
follows the appointment of Dr. Diane I. Duncan and Dr. Jack Zamora
in recent years, we are excited to further enhance our impressive
team of physician advisers to inform our clinical strategy as we
seek to become the world’s leading innovator in unique energy
solutions for the cosmetic surgery market.”
Brian M. Kinney, M.D.:
Dr. Brian M. Kinney is a Clinical Associate Professor of Plastic
Surgery at the University of Southern California in Los Angeles,
CA, and a board certified plastic surgeon. He is a co-founder and a
Board Member of the International Society of Plastic Regenerative
Surgery. Dr. Kinney is also an Editor of Aesthetic Plastic Surgery
(the “Blue Journal”) and the Archives of Plastic Surgery (Korea).
His is a past President of the Plastic Surgery Educational
Foundation, Board Member and Chairman of the Board of Trustees of
the American Society of Plastic Surgeons and Deputy Secretary
General of the International Confederation of Aesthetic, Plastic
and Reconstructive Surgeons. Dr. Kinney earned his bachelor’s
degree (Biomedical/Mechanical Engineering) and master’s degree
(Mechanical/Electrical Engineering) after completing the
Harvard/MIT Health Sciences and Technology program. He attended
medical school at Tulane University and trained in general surgery
and plastic surgery at UCLA in Los Angeles, CA.
Paul G. Ruff IV, M.D., FACS:
Dr. Paul G. Ruff IV is a double board certified private practice
plastic surgeon with over twenty years of experience. Dr. Ruff
trains and lectures nationally and internationally and has written
numerous book chapters. Energy, and the application of energy for
rejuvenation, is a particular and ever-evolving interest of his. He
is affiliated with the American Society of Plastic Surgeons, the
American Society for Aesthetic Plastic Surgery, the American
College of Surgeons and the American Society for Laser Medicine
& Surgery. Dr. Ruff earned his medical degree from the Eastern
Virginia Medical School. He performed his general surgery residency
and surgical critical care residency and was the chief
administrative resident at Washington Hospital Center. Dr. Ruff
completed his plastic surgery residency at the University of
California, San Diego Medical Center.
Richard D. Gentile, M.D., M.B.A.:
Dr. Richard D. Gentile is a distinguished Facial Plastic and
Reconstructive Surgeon, teacher and author who is respected
internationally for his innovation, artistry and technical skills
in the profession. Dr. Gentile founded the Facial Plastic and
Aesthetic Laser Center in 1987 and serves northern Ohio in his
specialized centers in Fairlawn and Boardman, Ohio. Prior to
entering full time private practice, he served as a Clinical
Associate Professor at the Northeast Ohio Medical University and
has served on the medical faculty of Case Western Reserve College
of Medicine in Cleveland, Ohio and the Baylor College of Medicine
in Houston, Texas. Dr. Gentile is certified by the American Board
of Facial Plastic and Reconstructive Surgery and by the American
Board of Otolaryngology – Head and Neck Surgery. He is a Fellow of
the American Academy of Facial Plastic and Reconstructive Surgery
and has served as an executive officer (Treasurer) for the Academy
and its research foundation, located in Alexandria, Virginia. Dr.
Gentile has also served as a national spokesman for the Academy,
and participates in most of its educational forums, having served
as a Program Chairman for the Academy’s 2004 Spring Meeting held in
Phoenix, Arizona. He also serves as an editorial reviewer for both
the Archives of Facial Plastic Surgery, published by the American
Medical Association, as well as the American Society for Laser
Medicine and Surgery. Dr. Gentile is a graduate of the Ohio State
University.
Edward M. Zimmerman, M.D.:
Dr. Edward M. Zimmerman is the President of, and an Examiner
for, the American Board of Laser Surgery, as well as a member of
the Board of Trustees for the American Academy of Cosmetic Surgery.
Dr. Zimmerman is also a member of the California Academy of
Cosmetic Surgery, the American Society for Laser Medicine and
Surgery and the American College of Physicians. He was voted Silver
State “Best Cosmetic Surgeon” in 2013 and 2014. Dr. Zimmerman
directs Aesthetic Revolution Las Vegas, a Nationally Accredited,
State licensed surgical facility dedicated to the refinement and
delivery of safe surgical and non-surgical aesthetic procedures.
The facility has been awarded “Excellence in Customer Care” by CMUS
Talk of the Town in 2010 through 2019. Dr. Zimmerman holds degrees
from Johns Hopkins, Georgetown and George Washington University
School of Medicine.
About Apyx Medical
Corporation:
Apyx Medical Corporation (formerly Bovie Medical Corporation) is
an advanced energy technology company with a passion for elevating
people’s lives through innovative products in the cosmetic and
surgical markets. Known for its innovative Helium Plasma
Technology, Apyx is solely focused on bringing transformative
solutions to the physicians and patients it serves. The company’s
Helium Plasma Technology is marketed and sold as Renuvion® in the
cosmetic surgery market and J-Plasma® in the hospital surgical
market. Renuvion offers plastic surgeons, fascial plastic surgeons
and cosmetic physicians a unique ability to provide controlled heat
to the tissue to achieve their desired results. The J-Plasma system
allows surgeons to operate with a high level of precision and
virtually eliminating unintended tissue trauma. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through original equipment manufacturing (OEM) agreements
with other medical device manufacturers. For further information
about the Company and its products, please refer to the Apyx
Medical Corporation website at www.ApyxMedical.com.
Cautionary Statement on Forward-Looking
Statements:
Certain matters discussed in this release and oral statements
made from time to time by representatives of the Company may
constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 and the Federal
securities laws. Although the Company believes that the
expectations reflected in such forward-looking statements are based
upon reasonable assumptions, it can give no assurance that its
expectations will be achieved.
Forward-looking information is subject to certain risks, trends
and uncertainties that could cause actual results to differ
materially from those projected. Many of these factors are beyond
the Company’s ability to control or predict. Important factors that
may cause actual results to differ materially and that could impact
the Company and the statements contained in this release can be
found in the Company’s filings with the Securities and Exchange
Commission including the Company’s Report on Form 10-K for the year
ended December 31, 2018 and subsequent Form 10-Q filings. For
forward-looking statements in this release, the Company claims the
protection of the safe harbor for forward-looking statements
contained in the Private Securities Litigation Reform Act of 1995.
The Company assumes no obligation to update or supplement any
forward-looking statements whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190715005063/en/
Investor Relations Contact:
Westwicke Partners on behalf of Apyx Medical Corporation Mike
Piccinino, CFA investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Apr 2024 to May 2024
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From May 2023 to May 2024